Canibrands Capitalizes on CBD with Deep Product Line & Celebrity Support
December 6th, 2019
App, Exclusive, News, Top Story
Cannabidiol, better known as CBD, has become one of the most popular wellness products in the United States over the past couple of years. BDS Analytics and Arcview Market Research expect CBD sales to grow at a 49% compound annual growth rate to surpass $20 billion by 2024—making up about half of the total cannabinoid industry—as sales shift from cannabis dispensaries to pharmacy and grocery stores.
CaniBrands brings extensive consumer packaged goods and branding experience to the CBD space, where it has developed a science-based product line encompassing numerous form factors and proprietary formulations. The company’s Can-i products are supported by 12-time Olympic medalist Dara Torres—its Global Spokesperson—and acclaimed high-performance trainer, Andy O’Brien—its Sports Science Advisor.
In a recent interview with CFN Media, Co-Founder and CEO Chris Lords discusses the company’s unique approach to the market and growing product line:
Holistic Approach with Many Choices
CaniBrands offers a premium product line that includes Can-i Boost, Can-i Sleep, Can-i Mend and Can-i Fresh, which are scientifically-formulated to deliver specific wellness benefits.
The company’s best-seller by revenue, Can-i Boost™, combines hemp-derived CBD with a powerful blend of vitamins and herbal extracts designed to keep you alert, energized and clear-headed without any crashes or jitters. Meanwhile, the company’s best-seller by volume, Can-i Sleep™, combines the same hemp-derived CBD with melatonin and other supplements designed to promote a healthy sleep cycle.
In addition to these best-selling products, the company’s Can-i Mend™ addresses pain, inflammation and soreness by accelerating the body’s healing process. The product is popular among athletes looking to cut recovery time and reduce post-workout soreness. And finally, the company’s Can-i Fresh™ is designed to deliver antioxidants, support the immune system and promote mental clarity on a day-to-day basis.
These products are available in multiple form factors, including a sublingual tincture, oral spray and cream, providing customers with many different choices. For example, many athletes appreciate creams to provide localized pain relief, whereas oral sprays provide a convenient on-the-go form factor for busy people. All of these products can be helpful at different times of the day from Can-i Boost™ in the morning to Can-i Sleep™ at night.
Active Expansion into New Markets
CaniBrands has been actively focused on establishing new distribution channels, expanding into new markets and launch new product lines.
The company began by building their own direct-to-consumer platform before moving onto Amazon Prime to access more households. Pilot programs are exploring the possibility of home delivery reselling in local markets, as well as online affiliate marketing, which could significantly expand its distribution and reach new customers throughout the United States that may not otherwise find them online.
Early next year, the company plans to launch its products in Canada before expanding into other international markets. The company’s Brand Ambassador, former NHL player and media personality Paul Bissonnette, will be integral in supporting the Canadian launch. Since becoming the first country to legalize recreational cannabis, Canada has been widely considered a leading market for cannabinoid-based products.
The company also aims to launch a variety of new product lines over time. For example, the company is exploring softgels, beverage, and other product formats (e.g. topicals, bars, and powders), as well as products containing other cannabinoids (e.g. CBN or CBG). The company’s CaniBuy™ ecommerce management platform also aims to integrate websites, ecommerce, payments and fulfillment into a single client-facing portal.
Gearing Up to Go Public in the Near-term
CaniBrands recently began a $5 million capital raise targeting accredited investors, and the founders and two strategic investors have already committed more than $1 million of the funding round. Management says that the proceeds will be put towards a variety of revenue-driving activities, as well as R&D and general operational expenses.
With no long-term debt, a seasoned management team, commercial products and a solid business model, the company is well-positioned to capitalize on the rapid growth of the CBD market over the coming years.
Accredited investors that are interested in participating in the funding round are encouraged to sign up to receive an investor presentation and corporate updates.
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.